BMP1 Promotes Keloid by Inducing Fibroblast Inflammation and Fibrogenesis
Journal of Cellular Biochemistry · 2024-07 · 125 (7)
DOI: 10.1002/jcb.30609 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Biochemistry, online erschienen am 11.06.2024. Verfasst von Yi Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Burns Surgery, The Second Hospital of Shandong University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Keloid, Fibroblasts, Bone Morphogenetic Protein 1, Inflammation. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Keloid is a typical fibrotic and inflammatory skin disease with unclear mechanisms and few therapeutic targets. In this study, we found that BMP1 was significantly increased in a collagen high‐expressing subtype of fibroblast by reanalyzing a public single‐cell RNA‐sequence data set of keloid. The number of BMP1‐positive fibroblast cells was increased in keloid fibrotic loci. Increased levels of BMP1 were further validated in the skin tissues and fibroblasts from keloid patients. Additionally, a positive correlation between BMP1 and the Keloid Area and Severity Index was found in keloid patients. In vitro analysis revealed collagen production, the phosphorylation levels of p65, and the IL‐1β secretion decreased in BMP1 interfered keloid fibroblasts. Besides, the knockdown of BMP1 inhibited the growth and migration of keloid fibroblast cells. Mechanistically, BMP1 inhibition downregulated the noncanonical TGF‐β pathways, including p‐p38 and p‐ERK1/2 signaling. Furthermore, we found the delivery of BMP1 siRNAs could significantly alleviate keloid in human keloid‐bearing nude mice. Collectively, our results indicated that BMP1 exhibited various pathogenic effects on keloids as promoting cell proliferation, migration, inflammation, and ECM deposition of fibroblast cells by regulating the noncanonical TGF‐β/p38 MAPK, and TGF‐β/ERK pathways. BMP1‐lowing strategies may appear as a potential new therapeutic target for keloid.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Plastic and Burns Surgery, The Second Hospital of Shandong University, Jinan, Shandong, China.
- Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
- Human Phenome Institute, Fudan University, Shanghai, China.
ORCID-Profile: Xiangguang Shi
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, Y., Chen, Y., Wu, J., & Shi, X. (2024). BMP1 Promotes Keloid by Inducing Fibroblast Inflammation and Fibrogenesis. Journal of Cellular Biochemistry, 125(7). https://doi.org/10.1002/jcb.30609
Vancouver
Wang Y, Chen Y, Wu J, Shi X. BMP1 Promotes Keloid by Inducing Fibroblast Inflammation and Fibrogenesis. Journal of Cellular Biochemistry. 2024;125(7). doi:10.1002/jcb.30609
BibTeX
@article{Wang2024,
author = {Wang, Yi and Chen, Yahui and Wu, Jinfeng and Shi, Xiangguang},
title = {BMP1 Promotes Keloid by Inducing Fibroblast Inflammation and Fibrogenesis},
journal = {Journal of Cellular Biochemistry},
year = {2024},
volume = {125},
number = {7},
doi = {10.1002/jcb.30609}
}
EUVIMED